Scotland: Hope for patients with pulmonary fibrosis
The Scottish Medicines Consortium (SMC) has announced that the anti-fibrotic medicine nintedanib has been accepted for use by NHS Scotland…
Nintedanib
Victory for thousands of terminally ill patients
Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than…